Skip to main navigation Skip to search Skip to main content

A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled-Released (CR) for the Treatment of Major Depressive Episode Associated with Bipolar I Disorder

Project: Research

Project Details

StatusFinished
Effective start/end date03/8/23 → 07/31/25

Funding

  • IQVIA Incorporated: $28,307.67